United States Federal Circuit
Abbott Labs. v. Andrx Pharms., Inc., 06-1101
In a suit alleging infringement of plaintiff's patents relating to extended release formulations of clarithromycin, grant of a preliminary injunction for plaintiff is affirmed where: 1) collateral estoppel does not apply, contrary to defendant's arguments; and 2) the district court did not abuse its discretion in finding that plaintiff is likely to succeed on the merits.
Appellate Information
- Decided 01/05/2007
- Published 01/05/2007
Judges
- PROST, Circuit Judge., Before MICHEL, Chief Judge, PROST, Circuit Judge, ELLIS, District Judge.
Court
- United States Federal Circuit
Counsel
- For Appellees:
- Jeffrey I. Weinberger, Munger, Tolles & Olson, LLP, of Los Angeles, CA, argued for plaintiff-appellee. With him on the brief was Ted G. Dane. Of Counsel on the brief were Jason Rantanen and Genevieve A. Cox, of San Francisco, CA., Eric D. Isicoff, Isicoff, Ragatz & Koenigsberg, of Miami, FL, argued for defendant-appellant. With him on the brief was Teresa Ragatz. Of counsel on the brief were Alan B. Clement, Martin P. Endres, and Katharine G. Loving, Hedman & Costigan, P.C., of New York, NY; and Steven H. Sklar, Leydig, Voit & Mayer, Ltd., of Chicago, IL.